{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:06:20Z","timestamp":1747181180219,"version":"3.40.5"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6,16]]},"abstract":"<jats:p>This study explored whether the risk of thyroid cancer in Asian women is associated with consumption of oral contraceptives (Diane-35). We conducted a population-based, retrospective cohort study using the Taiwan National Health Insurance Research Database. From the database, 9865 women aged 18 to 65 years who were prescribed Diane-35 between 2000 and 2012 were included in the Diane-35 group, and 39,460 women who were not prescribed Diane-35 were included in the comparison group and were frequency-matched by age and index year. Both groups were followed until 2013 to calculate the incidence of thyroid cancer. Hazard ratios (HR) and 95% confidence intervals (CI) were estimated using Cox proportional hazard model. The median (standard deviation) follow-up duration was 7.08 (3.63) and 7.04 (3.64) years in the Diane-35 and the comparison group, respectively. The incidence of thyroid cancer was 1.80-fold higher in the Diane-35 group than in the comparison group (2.72 vs 1.51 per 10,000 person-years). The cumulative incidence of thyroid cancer was significantly higher in the Diane-35 group than in the comparison group (log-rank test, <jats:italic toggle=\"yes\">P<\/jats:italic> = .03). An elevated hazard ratio of thyroid cancer was observed in the Diane-35 group than in the comparison group (HR: 1.91, 95% CI: 1.10\u20133.30). In subgroup analysis, patients aged 30 to 39 years showed a higher hazard ratio of developing thyroid cancer after consuming Diane-35 than those in the comparison group (HR: 5.58, 95% CI: 1.84\u201316.91). The study provides evidence that women aged 30 to 39 years consuming Diane-35 are at increased risk of thyroid cancer. Nevertheless, a larger population with a longer follow-up may be necessary to confirm causality.<\/jats:p>","DOI":"10.1097\/md.0000000000034074","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T18:02:00Z","timestamp":1686938520000},"page":"e34074","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Women consuming oral contraceptives containing cyproterone acetate and ethinylestradiol show a higher risk of thyroid cancer than nonusers"],"prefix":"10.1097","volume":"102","author":[{"given":"Pei-Hsuan","family":"Lai","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Foundation, and Tzu Chi University, Hualien, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weishan","family":"Chen","sequence":"additional","affiliation":[{"name":"Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan"},{"name":"College of Medicine, China Medical University, Taichung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung Y.","family":"Hsu","sequence":"additional","affiliation":[{"name":"Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jen-Hung","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Foundation, and Tzu Chi University, Hualien, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5105-068X","authenticated-orcid":false,"given":"Dah-Ching","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Foundation, and Tzu Chi University, Hualien, Taiwan"},{"name":"Institute of Medical Sciences, College of Medicine, Tzu Chi University, Hualien, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S1470-2045(15)00211-9","article-title":"The Pill\u2019s gestation: from birth control to cancer prevention.","volume":"16","author":"Wentzensen","year":"2015","journal-title":"Lancet Oncol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/09513590.2015.1101441","article-title":"Management of polycystic ovarian syndrome with Diane-35 or Diane-35 plus metformin.","volume":"32","author":"Feng","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1002\/hed.25945","article-title":"Reproductive factors and thyroid cancer risk: meta-analysis.","volume":"41","author":"Mannathazhathu","year":"2019","journal-title":"Head Neck"},{"key":"R5-20250504","first-page":"51","article-title":"Reproductive and menstrual history and papillary thyroid cancer risk: the San Francisco Bay Area thyroid cancer study.","volume":"11","author":"Sakoda","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"103515","DOI":"10.1155\/2015\/103515","article-title":"Reproductive factors but not hormonal factors associated with thyroid cancer risk: a systematic review and meta-analysis.","volume":"2015","author":"Cao","year":"2015","journal-title":"Biomed Res Int"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"593479","DOI":"10.3389\/fonc.2021.593479","article-title":"Signal pathway of estrogen and estrogen receptor in the development of thyroid cancer.","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3332\/ecancer.2017.748","article-title":"Immunohistochemical expression of ER-\u03b1 and PR in papillary thyroid carcinoma.","volume":"11","author":"Eldien","year":"2017","journal-title":"Ecancermedicalscience"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3390\/ijms23031242","article-title":"Estrogen receptors-mediated apoptosis in hormone-dependent cancers.","volume":"23","author":"Chimento","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.3390\/cancers15092458","article-title":"The tumor microenvironment and the estrogen loop in thyroid cancer.","volume":"15","author":"Denaro","year":"2023","journal-title":"Cancers"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3389\/fendo.2017.00111","article-title":"Female reproductive factors and differentiated thyroid cancer.","volume":"8","author":"Moleti","year":"2017","journal-title":"Front Endocrinol"},{"key":"R12-20250504","first-page":"66","article-title":"Risk factors for thyroid cancer: what do we know so far?","volume":"59","author":"Bogovi\u0107 Crn\u010di\u0107","year":"2020","journal-title":"Acta Clin Croat"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jfma.2015.10.011","article-title":"Incidence and survival of adult cancer patients in Taiwan, 2002-2012.","volume":"115","author":"Chiang","year":"2016","journal-title":"J Formos Med Assoc"},{"key":"R14-20250504","first-page":"1324","article-title":"Thyroid cancer risk in women with infertility and association with fertility medications in Taiwan: infertility and thyroid cancer.","volume":"99","author":"Ding","year":"2019","journal-title":"Cancer"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/aje\/kwu220","article-title":"Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in young women in France: a population-based case-control study.","volume":"180","author":"Xhaard","year":"2014","journal-title":"Am J Epidemiol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/j.canep.2011.05.009","article-title":"Hormonal and reproductive factors and risk of postmenopausal thyroid cancer in the NIH-AARP diet and health study.","volume":"35","author":"Schonfeld","year":"2011","journal-title":"Cancer Epidemiol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1007\/s13277-015-3165-0","article-title":"Increased risk of papillary thyroid cancer related to hormonal factors in women.","volume":"36","author":"Wang","year":"2015","journal-title":"Tumour Biol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejca.2017.07.012","article-title":"Menopausal hormone therapy and cancer risk: an overestimated risk?","volume":"84","author":"Simin","year":"2017","journal-title":"Eur J Cancer"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1158\/1055-9965.EPI-11-0381","article-title":"Hormonal factors and the risk of papillary thyroid cancer in the California Teachers Study cohort.","volume":"20","author":"Horn-Ross","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.7314\/APJCP.2013.14.9.5153","article-title":"Reproductive risk factors for thyroid cancer: a prospective cohort study in Khon Kaen, Thailand.","volume":"14","author":"Sungwalee","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"e29177","DOI":"10.1371\/journal.pone.0029177","article-title":"BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review.","volume":"7","author":"Peterson","year":"2012","journal-title":"PLoS One"},{"key":"R22-20250504","first-page":"991","article-title":"Reproductive and hormonal risk factors for thyroid cancer in Los Angeles County females.","volume":"8","author":"Mack","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/humrep\/deab285","article-title":"Fertility drugs and incidence of thyroid cancer in a Danish nationwide cohort of 146 024 infertile women.","volume":"37","author":"Lindquist","year":"2022","journal-title":"Hum Reprod"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"864852","DOI":"10.1155\/2015\/864852","article-title":"Progesterone upregulates gene expression in normal human thyroid follicular cells.","volume":"2015","author":"Bertoni","year":"2015","journal-title":"Int J Endocrinol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000452488","article-title":"Immunohistochemical expression of estrogen receptor-\u03b1 and progesterone receptor in patients with papillary thyroid cancer.","volume":"5","author":"Sturniolo","year":"2016","journal-title":"Eur Thyroid J"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/ct.2015;27.155-157","article-title":"Estrogen and progesterone receptors in papillary thyroid cancers do not affect outcome.","volume":"27","author":"Hershman","year":"2015","journal-title":"Clin Thyroidol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1093\/humrep\/dev160","article-title":"Linear reduction in thyroid cancer risk by oral contraceptive use: a dose-response meta-analysis of prospective cohort studies.","volume":"30","author":"Wu","year":"2015","journal-title":"Hum Reprod"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.canep.2017.04.001","article-title":"Hormonal and reproductive risk factors of papillary thyroid cancer: a population-based case-control study in France.","volume":"48","author":"Cordina-Duverger","year":"2017","journal-title":"Cancer Epidemiol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/jamaoncol.2018.5188","article-title":"Association between polycystic ovary syndrome and cancer risk.","volume":"5","author":"Yin","year":"2019","journal-title":"JAMA Oncol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1530\/EC-18-0309","article-title":"Association between PCOS and autoimmune thyroid disease: a systematic review and meta-analysis.","volume":"7","author":"Romitti","year":"2018","journal-title":"Endocr Connect"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s002680020165","article-title":"Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited.","volume":"25","author":"Kebebew","year":"2001","journal-title":"World J Surg"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12905-021-01376-4","article-title":"Oral contraceptives and hypertension in women: results of the enrolment phase of Tabari Cohort Study.","volume":"21","author":"Afshari","year":"2021","journal-title":"BMC Womens Health"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jama.280.6.533","article-title":"Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus.","volume":"280","author":"Kjos","year":"1998","journal-title":"JAMA"},{"key":"R34-20250504","first-page":"14","article-title":"Evaluation of lipid profile, high-sensitivity C-reactive protein and D-dimer in users of oral contraceptives of different types.","volume":"54","author":"Guedes","year":"2018","journal-title":"J Bras Patol Med Lab"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5468\/ogs.2013.56.3.137","article-title":"Dyslipidemia in women with polycystic ovary syndrome.","volume":"56","author":"Kim","year":"2013","journal-title":"Obstet Gynecol Sci"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"T273","DOI":"10.1530\/ERC-14-0053","article-title":"Estrogen and its role in thyroid cancer.","volume":"21","author":"Derwahl","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/cam4.4949","article-title":"Influence of the anti-oestrogens tamoxifen and letrozole on thyroid function in women with early and advanced breast cancer: a systematic review.","volume":"12","author":"Marina","year":"2023","journal-title":"Cancer Med"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3389\/fonc.2020.01702","article-title":"Epidemiology of thyroid cancer: incidence and mortality in China, 2015.","volume":"10","author":"Du","year":"2020","journal-title":"Front Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034074","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:09:25Z","timestamp":1746320965000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":37,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034074","relation":{},"ISSN":["0025-7974"],"issn-type":[{"type":"print","value":"0025-7974"}],"subject":[],"published":{"date-parts":[[2023,6,16]]}}}